Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scripps Research study reveals new function of protein kinase pathway in tumor suppression

26.01.2007
Discovery could lead to drug development for cancer treatment

The study, led by Associate Professor Peiqing Sun and Professor Jiahuai Han of The Scripps Research Institute, is being published on January 26, 2007 in the journal Cell.

The research focused on signaling pathways that mediate an anti-tumor defense response called senescence, or cellular aging. The research, which was conducted in both human cell culture and rodent models with skin cancer or lymphoma, identified one essential element of this anti-tumor response, namely, p38-regulated/activated protein kinase (PRAK). Previous to this research, PRAK's physiological functions had been poorly understood.

"In uncovering this basic mechanism, we've advanced our knowledge in terms of how cancers develop," Sun said. "More importantly, we have identified a pathway in normal cells that, when activated, can inhibit tumor development. This lays the groundwork for new cancer therapy--for future drug development to artificially activate this pathway in cancer cells."

The human body has several built-in mechanisms that prevent cancer development. One is cell death, or apoptosis. Another is premature senescence, a recently identified tumor-restricting response that permanently stops cell proliferation.

"A normal cell stops dividing when it gets old," Sun explained. "This is referred to as senescence of a cell. A young cell will become senescent prematurely when it acquires a mutation that activates an oncogene. This is one of the ways our body tries to eliminate cells that might become cancerous."

In previous research that set the stage for this current project, Sun's lab worked to identify the signaling cascade that mediates ras-induced premature senescence (ras is an oncogene, a gene that, when activated by mutations, causes cancer by transducing unrestricted growth signals). Using human cells in culture, Sun's team showed that the p38 mitogen-activated protein (MAP) kinase is required for ras to induce senescence in cell culture.

"After these findings, we wanted to look downstream of p38 to see exactly how this MAP kinase mediates senescence," Sun explained. "We knew the effect of p38 is achieved through its ability to regulate its downstream substrates, so we started to investigate various substrate candidates to see which ones were involved."

Fortunately, Sun added, his research team could easily link up with a leading expert in the p38 field, Professor Jiahuai Han. The p38 gene was cloned by Han in 1994. Since then, the Han lab has identified some p38 downstream protein kinases, including PRAK, and has shown that PRAK can be activated by various stresses. The Han research group also engineered PRAK knockout mice, animals that lack the PRAK gene, expecting that these mice would be defective in stress response. To the researchers' surprise, the mice responded normally to stresses, an indication that this gene may not be required for the stress pathway.

Joining forces, Sun and Han collaborated to investigate the role of PRAK in senescence response and tumor suppression. They also enlisted the expertise of Scripps Research investigators John Yates and Peter Wright and their laboratory groups.

What the researchers found was that PRAK is required for ras to induce senescence in vitro in normal cells derived from a mouse. They also did an experiment to see if the lack of PRAK would make a difference in senescence induction in human cells. The team introduced double-strand RNA into normal human fibroblast cells to inhibit the expression of PRAK and then activated the ras oncogene in these cells. The results were identical to those in mouse cells. When PRAK was inactivated in normal human cells, these cells did not undergo premature senescence.

"These experiments tell us that PRAK in both human cells and in mouse cells is an essential component that mediates ras-induced senescence," said Sun.

The researchers wanted, next, to find out whether PRAK was essential for ras-induced senescence in vivo, and whether deletion of the PRAK gene would make a difference in the ras-induced tumor-development process in PRAK knockout mice. A group of these mice and a group of normal mice were treated with DMBA, an environmental pollutant found in cigarette smoke and gas emissions, which can induce ras mutations and cause skin tumor formation. The researchers monitored the incidence of skin tumor formation in these mice, and after tumors formed, the degree of cell senescence in the tumors. The results, Sun said, were exciting.

"The mice lacking the PRAK gene were more susceptible to skin tumor induction by DMBA, as compared to wild-type mice," Sun said. "This indicates that the presence of the normal PRAK gene suppresses tumor formation. In the wild-type, normal mice, DMBA induced premature senescence, but in the knockout tumors there were no senescent cells. The PRAK knockout animals were resistant to ras-induced senescence but prone to tumor induction, which led us to the happy conclusion that PRAK and the senescence response mediated by PRAK has a tumor-suppressing function in vivo. The knockout mice were more vulnerable to tumor induction because the senescence pathway, which is responsible for the anti-tumor self-defense mechanism, had been compromised. In addition to the skin cancer model, loss of the PRAK gene in mice also accelerates lymphoma development, which indicates that PRAK may be involved in suppressing tumor formation in multiple tissues."

Keith McKeown | EurekAlert!
Further information:
http://www.scripps.edu

Further reports about: Han Kinase PRAK Ras mediate p38 premature ras-induced senescence tumor formation

More articles from Life Sciences:

nachricht Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute

nachricht Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>